Jim Simons’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jim Simons’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$812K	Buy	+19,300	New	+$615K	﹤0.01%	2413
2026 Q1	–	Sell	-67,700	Closed	-$1.96M	–	3242
2025 Q4	$1.96M	Sell	67,700 -15,600	-19%	-$468K	﹤0.01%	1883
2025 Q3	$2.31M	Buy	+83,300	New	+$2.1M	﹤0.01%	1974
2022 Q4	–	Sell	-17,800	Closed	-$585K	–	4098
2022 Q3	$585K	Buy	+17,800	New	+$653K	﹤0.01%	2833
2022 Q2	–	Sell	-57,600	Closed	-$2.65M	–	4201
2022 Q1	$2.65M	Buy	57,600 +16,200	+39%	+$772K	﹤0.01%	2011
2021 Q4	$2.54M	Buy	+41,400	New	+$2.86M	﹤0.01%	1963

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jim Simons's ARKG Position: Q2 2026 in Review

Jim Simons opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 19,300 shares worth $812K. The stake represents ﹤0.01% of the portfolio and ranks #2413 among its holdings. This is a return to the name: Jim Simons previously reported a position in ARKG as recently as Q4 2025.

Jim Simons first reported a position in ARKG in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.65M in Q1 2022. 276 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Jim Simons held 19,300 shares of ARK Genomic Revolution ETF worth $812K as of Q2 2026.
ARK Genomic Revolution ETF was a new Jim Simons position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2413 holding.
Jim Simons first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 6 quarters since.
Jim Simons's ARK Genomic Revolution ETF position peaked at $2.65M in Q1 2022.
276 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.